TCTP in Development and Cancer

The translationally controlled tumor protein (TCTP) is highly conserved among animal species. It is widely expressed in many different tissues. It is involved in regulating many fundamental processes, such as cell proliferation and growth, apoptosis, pluripotency, and the cell cycle. Hence, it is not surprising that it is essential for normal development and, if misregulated, can lead to cancer. Provided herein is an overview of the diverse functions of TCTP, with a focus on development. Furthermore, we discuss possible ways by which TCTP misregulation or mutation could result in cancer.

[1]  J. Marine,et al.  Reciprocal repression between P53 and TCTP , 2011, Nature Medicine.

[2]  Junlin He,et al.  Expression of translationally controlled tumor protein (TCTP) in the uterus of mice of early pregnancy and its possible significance during embryo implantation. , 2011, Human reproduction.

[3]  J. Gurdon,et al.  Nuclear actin polymerization is required for transcriptional reprogramming of Oct4 by oocytes. , 2011, Genes & development.

[4]  S. Rho,et al.  Anti‐apoptotic protein TCTP controls the stability of the tumor suppressor p53 , 2011, FEBS letters.

[5]  M. Lindström.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling , 2010, Biochemistry research international.

[6]  P. Cappella,et al.  Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo. , 2010, Anticancer research.

[7]  E. Yarmola,et al.  Identification of a cofilin‐like actin‐binding site on translationally controlled tumor protein (TCTP) , 2010, FEBS letters.

[8]  G. Salvesen,et al.  Regulation of the Apaf-1–caspase-9 apoptosome , 2010, Journal of Cell Science.

[9]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[10]  M. Bendahmane,et al.  Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants , 2010, Proceedings of the National Academy of Sciences.

[11]  S. Simonsson,et al.  Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells , 2010, Cell cycle.

[12]  T. Veenstra,et al.  Plk1-dependent and -independent roles of an ODF2 splice variant, hCenexin1, at the centrosome of somatic cells. , 2009, Developmental cell.

[13]  J. Labbé,et al.  Chfr interacts and colocalizes with TCTP to the mitotic spindle , 2008, Oncogene.

[14]  J. Marine,et al.  Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice , 2008, Cell Death and Differentiation.

[15]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[16]  J. Marine,et al.  TCTP protects from apoptotic cell death by antagonizing bax function , 2008, Cell Death and Differentiation.

[17]  J. Kubiak,et al.  Temporal regulation of embryonic M-phases. , 2008, Folia histochemica et cytobiologica.

[18]  H. Yang-Yen,et al.  A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. , 2007, Molecular biology of the cell.

[19]  Pei-jun Zhang,et al.  The expression of AmphiTCTP, a TCTP orthologous gene in amphioxus related to the development of notochord and somites. , 2007, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[20]  H. Shimada,et al.  Bovine oocytes with the potential to reprogram somatic cell nuclei have a unique 23-kDa protein, phosphorylated transcriptionally controlled tumor protein (TCTP). , 2007, Cloning and stem cells.

[21]  J. Gurdon,et al.  Tpt1 Activates Transcription of oct4 and nanog in Transplanted Somatic Nuclei , 2007, Current Biology.

[22]  Mingyao Liu,et al.  Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase , 2007, Nature.

[23]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[24]  Austin G Smith,et al.  Nanog promotes transfer of pluripotency after cell fusion , 2006, Nature.

[25]  J. Brickman,et al.  Conserved roles for Oct4 homologues in maintaining multipotency during early vertebrate development , 2006, Development.

[26]  R. Medema,et al.  Polo-Like Kinases: A Team in Control of the Division , 2006, Cell cycle.

[27]  K. Kinnally,et al.  Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. , 2006, Biochimica et biophysica acta.

[28]  P. Pandolfi,et al.  Role of nucleophosmin in embryonic development and tumorigenesis , 2005, Nature.

[29]  Xiaofeng Yang,et al.  An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity , 2005, Oncogene.

[30]  M. V. Vugt,et al.  Getting in and out of mitosis with Polo-like kinase-1 , 2005, Oncogene.

[31]  H. Yang-Yen,et al.  Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP , 2005, Molecular and Cellular Biology.

[32]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[33]  B. Goud,et al.  TSAP6 Facilitates the Secretion of Translationally Controlled Tumor Protein/Histamine-releasing Factor via a Nonclassical Pathway* , 2004, Journal of Biological Chemistry.

[34]  D. Moras,et al.  Translationally controlled tumor protein is a target of tumor reversion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[36]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[37]  M. Mirande,et al.  Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[39]  J. Nichols,et al.  BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3 , 2003, Cell.

[40]  S. Simonsson,et al.  Nuclei of Adult Mammalian Somatic Cells Are Directly Reprogrammed to oct-4 Stem Cell Gene Expression by Amphibian Oocytes , 2003, Current Biology.

[41]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[42]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[43]  H. Schöler,et al.  Stem cell pluripotency and transcription factor Oct4 , 2002, Cell Research.

[44]  S. Prieur,et al.  Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  F. Yarm.  Plk Phosphorylation Regulates the Microtubule-Stabilizing Protein TCTP , 2002, Molecular and Cellular Biology.

[46]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[47]  P. Russell,et al.  The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. , 2002, RNA.

[48]  James K. Chen,et al.  The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition , 2002, The Journal of cell biology.

[49]  K. Fujise,et al.  Characterization of Fortilin, a Novel Antiapoptotic Protein* , 2001, The Journal of Biological Chemistry.

[50]  C. Holding,et al.  Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.

[51]  S. Fesik,et al.  Controlling the Caspases , 2001, Science.

[52]  Peter J. Donovan,et al.  The end of the beginning for pluripotent stem cells , 2001, Nature.

[53]  Norio Nakatsuji,et al.  Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells , 2001, Current Biology.

[54]  D. Hochstrasser,et al.  Cellular distribution of translationally controlled tumor protein in rat and human testes , 2001, Proteomics.

[55]  H. Schöler,et al.  Oct‐4: Gatekeeper in the Beginnings of Mammalian Development , 2001, Stem cells.

[56]  H. Schöler,et al.  Expression Pattern of Oct-4 in Preimplantation Embryos of Different Species , 2000, Biology of reproduction.

[57]  B. Thiele,et al.  Expression of the gene and processed pseudogenes encoding the human and rabbit translationally controlled tumour protein (TCTP). , 2000, European journal of biochemistry.

[58]  T. Halazonetis,et al.  Chfr defines a mitotic stress checkpoint that delays entry into metaphase , 2000, Nature.

[59]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[60]  G. Thomas,et al.  Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.

[61]  Ronit Vogt Sionov,et al.  The cellular response to p53: the decision between life and death , 1999, Oncogene.

[62]  A. Bellamy,et al.  Expression of translationally controlled tumour protein is regulated by calcium at both the transcriptional and post-transcriptional level. , 1999, The Biochemical journal.

[63]  Akihiko Okuda,et al.  The Gene for the Embryonic Stem Cell Coactivator UTF1 Carries a Regulatory Element Which Selectively Interacts with a Complex Composed of Oct-3/4 and Sox-2 , 1999, Molecular and Cellular Biology.

[64]  S. Gygi,et al.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.

[65]  Y. Gachet,et al.  The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. , 1999, Journal of cell science.

[66]  A. Cuddihy,et al.  Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53 , 1999, Molecular and Cellular Biology.

[67]  K. Rokutan,et al.  Macrophage colony-stimulating factor stimulates synthesis and secretion of a mouse homolog of a human IgE-dependent histamine-releasing factor by macrophages in vitro and in vivo. , 1998, Journal of immunology.

[68]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[69]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[70]  S. Schreiber,et al.  Translation control: Connecting mitogens and the ribosome , 1998, Current Biology.

[71]  R. Pearson,et al.  Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.

[72]  T. Rafnar,et al.  Molecular identification of an IgE-dependent histamine-releasing factor. , 1995, Science.

[73]  H. Schöler,et al.  Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. , 1994, Developmental biology.

[74]  A. Gingras,et al.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.

[75]  G. Yancopoulos,et al.  LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. , 1993, Science.

[76]  H. Schöler,et al.  Oct‐4: a germline‐specific transcription factor mapping to the mouse t‐complex. , 1990, The EMBO journal.

[77]  Hans R. Schöler,et al.  New type of POU domain in germ line-specific protein Oct-4 , 1990, Nature.

[78]  H. Schöler,et al.  A family of octamer‐specific proteins present during mouse embryogenesis: evidence for germline‐specific expression of an Oct factor. , 1989, The EMBO journal.

[79]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[80]  John K. Heath,et al.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.

[81]  J. Rommelaere,et al.  Minute virus of mice inhibits cell transformation by simian virus 40 , 1982, Nature.

[82]  G. Brawerman,et al.  Messenger RNA species partially in a repressed state in mouse sarcoma ascites cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[83]  G. Thomas,et al.  Transcriptional and translational control of cytoplasmic proteins after serum stimulation of quiescent Swiss 3T3 cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Gurdon,et al.  Gene activation in somatic nuclei after injection into amphibian oocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[85]  G. Klein,et al.  Suppression of Malignancy by Cell Fusion , 1969, Nature.

[86]  L. Drobnica,et al.  Proliferation of Mycobacterium tuberculosis from Mouse Lung Tissue on Various Carbon Sources , 1967, Nature.

[87]  H. Toolan,et al.  Lack of Oncogenic Effect of the H-Viruses for Hamsters , 1967, Nature.

[88]  J. Gurdon,et al.  Adult frogs derived from the nuclei of single somatic cells. , 1962, Developmental biology.

[89]  T. Elsdale,et al.  Sexually Mature Individuals of Xenopus laevis from the Transplantation of Single Somatic Nuclei , 1958, Nature.